SCHOTT Pharma AG & Co. KGaA/€1SXP
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About SCHOTT Pharma AG & Co. KGaA
SCHOTT Pharma AG & Co. KGaA specializes in the design and manufacture of drug containment and delivery solutions for injectable medications, including prefillable glass and polymer syringes, cartridges, vials, and ampoules. Established as a standalone entity in August 2022 following its separation from SCHOTT AG, the company is headquartered in Mainz, Germany, and operates 16 manufacturing sites across Europe, North and South America, and Asia. With a portfolio of over 1,000 patents and a dedicated R&D center in Switzerland, SCHOTT Pharma focuses on developing innovative solutions to meet the evolving needs of the pharmaceutical industry. The company serves over 1,800 customers, including the top 30 pharmaceutical manufacturers for injectable drugs, and reported revenues of €821 million in the fiscal year 2022. SCHOTT Pharma is committed to sustainable development, aiming to achieve climate neutrality by 2030.
Ticker
€1SXP
Sector
Primary listing
XETRA
Employees
4,775
Headquarters
Website
1SXP Metrics
BasicAdvanced
€3.5B
24.05
€0.97
-
€0.16
0.69%
Price and volume
Market cap
€3.5B
52-week high
€36.62
52-week low
€18.50
Average daily volume
11K
Dividend rate
€0.16
Financial strength
Current ratio
1.571
Quick ratio
0.731
Long term debt to equity
9.289
Total debt to equity
33.314
Dividend payout ratio (TTM)
16.41%
Interest coverage (TTM)
10.92%
Profitability
EBITDA (TTM)
269.389
Gross margin (TTM)
33.73%
Net profit margin (TTM)
15.05%
Operating margin (TTM)
20.38%
Effective tax rate (TTM)
23.18%
Revenue per employee (TTM)
€200,000
Management effectiveness
Return on assets (TTM)
8.49%
Return on equity (TTM)
18.05%
Valuation
Price to earnings (TTM)
24.049
Price to revenue (TTM)
3.606
Price to book
4.1
Price to tangible book (TTM)
4.25
Price to free cash flow (TTM)
70.972
Free cash flow yield (TTM)
1.41%
Free cash flow per share (TTM)
0.329
Dividend yield (TTM)
0.69%
Forward dividend yield
0.69%
Growth
Revenue change (TTM)
2.86%
Earnings per share change (TTM)
-2.82%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for SCHOTT Pharma AG & Co. KGaA stock?
SCHOTT Pharma AG & Co. KGaA (1SXP) has a market cap of €3.5B as of August 21, 2025.
What is the P/E ratio for SCHOTT Pharma AG & Co. KGaA stock?
The price to earnings (P/E) ratio for SCHOTT Pharma AG & Co. KGaA (1SXP) stock is 24.05 as of August 21, 2025.
Does SCHOTT Pharma AG & Co. KGaA stock pay dividends?
Yes, the SCHOTT Pharma AG & Co. KGaA (1SXP) stock pays dividends to shareholders. As of August 21, 2025, the dividend rate is €0.16 and the yield is 0.69%. SCHOTT Pharma AG & Co. KGaA has a payout ratio of 16.41% on a trailing twelve-month basis.
When is the next SCHOTT Pharma AG & Co. KGaA dividend payment date?
The next SCHOTT Pharma AG & Co. KGaA (1SXP) dividend payment date is unconfirmed.
What is the beta indicator for SCHOTT Pharma AG & Co. KGaA?
SCHOTT Pharma AG & Co. KGaA (1SXP) does not currently have a Beta indicator.